Synopsis: CLSA maintained an Outperform rating on State Bank of India with a ₹1,275 target price, citing attractive valuation, margin recovery potential, and strong long-term growth outlook. This PSU Bank Stock, engaged in providing banking and financial services,...
Synopsis: CLSA has maintained a high-conviction ‘Outperform’ rating on Indus Towers with a target price of Rs. 580, implying an upside of nearly 31 percent, driven by rising tower tenancies from Bharti Airtel and Vodafone Idea, strong free cash flow generation, and...
Synopsis: India’s largest private airport operator turned the corner in FY26, reporting its first full-year profit in more than ten years as consolidated gross income surged 40% to Rs.15,201 crore and EBITDA scaled a record Rs.6,150 crore, with the Delhi...
Synopsis: A defence-focused explosives maker lands a major international deal worth Rs 1,076 Crore, adding to an already bulging order book even as its full-year profits crossed Rs 1,700 crore. India’s leading industrial explosives and defence products...
Synopsis: Strong order inflows and rising segment revenues signal deepening demand for smart infrastructure, rail mobility, and industrial automation across India’s growing economy. India’s push to modernise its factories, electrify its railways, and build...
Synopsis: Motilal Oswal maintained a ‘Buy’ rating on Lenskart with a target price of Rs.650, implying nearly 31 percent upside, after the company reported a blockbuster Q4 FY26 with adjusted PAT surging 165 percent YoY, EBITDA doubling, and volumes rising 25 percent,...
Synopsis: A construction and engineering giant closes out a remarkable month with a hat-trick of ground and waterway infrastructure wins, adding to an already impressive order haul in May. May 2026 has shaped up to be one of the busiest order-win months in recent...
Synopsis: This company share can deliver up to 63 percent upside, driven by strong Q4 FY26 pre-sales of Rs 20,100 crore and sustained demand in the luxury housing segment. The share of this company, which specializes in producing complex molecules and finished dosage...
Synopsis: The share of this hospital company fell 7.3 percent despite reporting strong Q4 FY26 growth, as rising expansion costs and margin pressure weighed on investor sentiment. The share of this company, which is one of India’s largest private, for-profit...
Synopsis: VBL jumps 3% after extending its exclusive PepsiCo bottling and trademark licence in India till April 30, 2049, replacing the 2039 expiry. The revised pact removes SPV restrictions, giving Varun Beverages greater flexibility beyond PepsiCo operations as it...
